Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-18
1998-12-01
Huang, Evelyn
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142328, 514253, 514256, 544115, 544238, 544333, 544405, 546 82, A61K 3147, A61K 31495, C07D21546, C07D47104
Patent
active
058439560
ABSTRACT:
Substituted N-arylmethyl and compositions containing them and methods for a) effecting c-GMP-phosphodiesterase inhibition, b) treating heart failure and/or hypertension, c) reversing or reducing nitrate-induced tolerance and d) treating angina pectoris, congestive heart disease and myocardial infarction utilizing them.
REFERENCES:
patent: 4013665 (1977-03-01), Crenshaw et al.
Stein et al, J. Med. Chem. 1970, 13(10), 153-155.
Zikan et al, Chem. Abstracts 108:204613K 1988.
Zikan et al, Chem. Abstracts 106:138447q 1987.
Radl et al, Chem. Abstracts 106:18429P 1987.
Radl et al, Chem. Abstracts 105:226434T 1986.
Crenshaw et al, J. Med. Chem., 1976, 19(2), 626-275.
Abrams J. The American Journal of Medicine 91 (suppl 3C), 1065-1125, Sep. 1991.
Nicholson C. D. et al. TIPS 12, 19-27, Jan. 1991.
Dority, Jr. John Alan
Kumar Virendra
Alexander Michael D.
Bauman Mary P.
Dupont. Paul E.
Huang Evelyn
Sanofi
LandOfFree
Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395889